Product Information
MIRTAZAPINE 30 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.0885 per EA under NDC 13107000330. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Oct 22, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107000330
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MIRTAZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA076921FDA Approved
10/22/2004
TE Code
AB
On Market Since
8/17/2009
Price Statistics
The NADAC for MIRTAZAPINE 30 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 37.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0885 per EA |
|---|---|
| All-time high | $0.2592 (Aug 13, 2014) |
| All-time low | $0.0716 (Nov 20, 2024) |
| 52-week high | $0.0908 |
| 52-week low | $0.0858 |
| Median price | $0.1104 |
| Average price | $0.1237 |
| Largest weekly change | +24.5% (Dec 23, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurolife Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mirtazapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIRTAZAPINE 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIRTAZAPINE 30 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.0885 per EA (NDC 13107000330), effective Sep 30, 2026.
How has the price of MIRTAZAPINE 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIRTAZAPINE 30 MG TABLET has declined 37.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MIRTAZAPINE 30 MG TABLET?
Since Nov 28, 2013, the NADAC for MIRTAZAPINE 30 MG TABLET has ranged from a low of $0.0716 (Nov 20, 2024) to a high of $0.2592 (Aug 13, 2014), with a median of $0.1104 per EA.
Are there cheaper alternatives to MIRTAZAPINE 30 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MIRTAZAPINE 30 MG TABLET, is $0.0723 per EA — about 18% below MIRTAZAPINE 30 MG TABLET.
Who manufactures MIRTAZAPINE 30 MG TABLET?
MIRTAZAPINE 30 MG TABLET (NDC 13107000330) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.